Sort   by:  
 Page size 
VRK1 plays a significant role in the growth and drug resistance of prostate cancer.
ORGANISM(S): Homo Sapiens 
2024-11-22 | PXD058205 |
Vaccinia related kinase (VRK) family is a ser/threonine kinase. VRK1 and VRK3 are localized in the same organelle, mainly in the nucleus. Comparative interactomes of VRK1 and VRK3 were not performed yet. We identified over 200 unreported VRK1/3-interacting proteins by proteomics-based analyses using...
ORGANISM(S): Homo sapiens (Human) 
2018-10-26 | PXD004103 | Pride
Chromatin organization and its dynamic remodeling determine its accessibility and sensitivity to DNA damage. The major source of endogenous DNA damage is oxidative stress. We studied the role of the VRK1 chromatin kinase in the response to oxidative stress, which alters the nuclear phosphoproteome a...
ORGANISM(S): Homo sapiens (Human) 
2024-05-24 | PXD040944 | Pride
Transcriptome analysis of testicular cells in VRK1+/+ and VRK1-/- Mus musculus
ORGANISM(S): Mus musculus 
2013-11-21 | GSE19329 | GEO
Transcriptome analysis of testicular cells in VRK1+/+ and VRK1-/- Mus musculus Gene expression in whole testicular cells from wild type (VRK1+/+) and VRK1-/- mutant Mus musculus, respectively, was measured. Four independent experiment for wild type and mutant, respectively, were performed.
ORGANISM(S): Mus musculus 
Collateral lethality occurs when loss of one paralog renders cancer cells dependent on the remaining paralog. Combining genome scale CRISPR/Cas9 screens coupled with RNA-sequencing in over 900 cancer cell lines, we found that cancers of nervous system lineage, including adult and pediatric gliomas a...
ORGANISM(S): Homo sapiens (Human) 
2022-09-06 | PXD030599 | Pride
VRK1 phosphorylates SRRM2 for the regulation of splicing of DNA damage repair factors
To understand the effects of VRK1 knockdown on global phospho- and total- proteomics we profiled the U251MG VRK2-low and VRK2-high cell lines at 5- and 7-days post-doxycycline treatment.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2022-07-01 | MSV000089783 | MassIVE
VRK1 is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the Cervix
To study effect of VRK1 deletion on spermatogenesis of the mouse, transciptomic analysis of genes in postnatal 8-day testicular cells of wild type and VRK1-deficient Mus musculus was performed.
ORGANISM(S): Mus musculus 
2011-12-30 | GSE22674 | GEO
Sort   by:  
 Page size